Matthew Ong named to the Poynter, Washington Post Leadership Academy for Diversity in Digital Media

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Matthew Bin Han Ong, associate editor of The Cancer Letter, was named by the Poynter Institute and The Washington Post to the Leadership Academy for Diversity in Digital Media.

Ong is part of a class of 32 journalists who were selected from over 130 applicants, who “are pioneers in digital media who have demonstrated an aptitude for leadership through current projects and references.”

They were selected by a committee that included graduates of the program, with an emphasis on ensuring diversity across race and ethnicity, geography, technology platforms, organization size and skill sets.

“The need for diversity in newsroom leadership isn’t new, but the urgency is greater than ever as we have seen from the racial reckoning happening across our industry. This academy not only better equips participants to lead through times of uncertainty, but it provides them with an essential network of fellow managers to support them as they grow in their careers,” Doris Truong, Poynter’s director of training and diversity, said in a statement Aug. 5. “Together, they are going to be extremely powerful in their work to ensure inclusion and equity—not only from fellow staff members but also in the types of news and the communities they cover.”

Ong will join a network of over 100 inductees.

“The Washington Post is committed to deepening the national conversation on issues of race and identity,” Carla Broyles, senior editor at The Post, said in a statement. “Partnering with Poynter furthers that commitment by providing a leadership training platform where journalists of color can find community and strengthen their skills for the critical work ahead.”

The Academy is also sponsored by CNN, Craig Newmark Philanthropies, the Scripps Howard Foundation, TEGNA Foundation, and the Ethics and Excellence Journalism Foundation.

YOU MAY BE INTERESTED IN

For nearly 25 years, business executive Lou Weisbach and urologist Richard J. Boxer have argued that finding the money to finance the cures for devastating diseases is not as difficult as it appears. To start finding the cures, the U.S. Department of the Treasury needs to issue some bonds—$750 billion worth. Next, you hire CEOs—one...

There is general agreement that the United States spends too much on health care, especially on pharmaceuticals.  But what we spend on drugs is not simply a function of price. If eggs double in price, people can simply cut the number of eggs they eat in half.  Simply stated, cost is the product of (price per unit times the number of units purchased). 
What did President Richard M. Nixon and Senator Edward M. Kennedy have in common? They each played a pivotal role in the passage of the National Cancer Act signed by Nixon on Dec. 23, 1971. The NCA established the National Cancer Program authorizing the initial investment in the NCI-designated Cancer Centers Program. 
When I first proposed targeting PCNA (proliferating cell nuclear antigen) as a therapeutic approach, the response I got was: “No one will ever make a drug against PCNA. It’s undruggable.” The protein lacks enzymatic activity, has a disordered region, and binds to over 200 other proteins within the cell. From a traditional drug development perspective, these characteristics made PCNA an impossible target.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login